Skip to Content

Image-Guided Therapy Group

Principal Investigator: Robert Jeraj
Office: WIMR 7033
Tel: 608-263-8619

The main research focus of the Image-Guided Therapy Group is understanding tumor heterogeneity, and the related origins and development of treatment resistance. We are studying tumor heterogeneity and treatment resistance in numerous clinical trials with extensive imaging endpoints for different types of interventions, such as radiation therapy, chemotherapy and molecular targeted therapies (e.g., VEGFR TKI, AR-directed therapies). We are developing a number of imaging biomarkers based on quantitative molecular imaging techniques to quantify spatio-temporal development of tumor heterogeneity and treatment resistance. We are modeling tumor progression based on imaging inputs to better understand complex relationships leading to tumor heterogeneity and treatment resistance.

Heterogeneity & Resistance Clinical Trials Modeling Imaging Biomarkers

Copyright © 2011 The Board of Regents of the University of Wisconsin System